期刊文献+

地塞米松对儿童原发性系膜增生性肾炎外周血淋巴细胞CTLA-4表达和凋亡的影响

Effects of dexamethasone on CTLA-4 expression and apoptosis in lymphocytes obtained from children with mesangial proliferative nephritis
原文传递
导出
摘要 目的原发性系膜增生性肾炎(MsPGN)的发病机制和糖皮质激素(GC)耐药机制虽然部分已明确,但其确切机制仍未阐明。细胞毒性T淋巴细胞相关抗原(CTLA-4)是T细胞活化的重要抑制性分子。本研究探讨MsPGN患儿外周血淋巴细胞CTLA-4表达和淋巴细胞凋亡及地塞米松(Dex)对其影响。方法分别采用直接免疫荧光、流式细胞仪及AnnexinV-FITC/PI双染流式细胞仪检测Dex处理或非Dex处理的MsPGN组和对照组体外培养外周血淋巴细胞膜CTLA-4的表达和其凋亡。结果体外培养MsPGN组淋巴细胞CTLA-4的自然表达和Dex诱导的表达均较对照组低(P<0.05);MsPGN组淋巴细胞自然凋亡和Dex诱导的凋亡亦较对照组低(P<0.05),且两者均呈正相关性(P<0.05)。结论CTLA-4表达异常可能参与了MsPGN的发病机制及GC耐药机制。 Objective The pathogenesis of mesangial proliferative glomerulonephritis(MsPGN)and mechanisms of glucocorticoid(GC)resistance have not been fully identified.Cytotoxic T-lymphocyte antigen-4(CTLA-4)is an important inhibitor of T-lymphocyte activation.The objective of the study is to investigate the CTLA-4 expression and apoptosis in lymphocytes of children with MsPGN and the effects of dexamethasone(Dex)on the CTLA-4 expression and apoptosis.Methods Blood samples were collected from 36 children with MsPGN and 30 healthy children.CTLA-4 expression in in vitro cultured lymphocytes with or without Dex treatment was measured by flow cytometry following direct immune fluorescene.The rate of apoptosis in the lymphocytes was evaluated by annexin V-FITC and propidium iodide staining.Results The CTLA-4 expression and apoptosis in lymphocytes from children with MsPGN were significantly lower than those in the healthy control children in the absence or presence of Dex treatment(P〈0.05).There was a positive correlation between CTLA-4 expression and apoptosis in lymphocytes(P〈0.05).Conclusions Abnormal CTLA-4 expression may participate in the pathogenesis of MsPGN and be one of mechanisms of GC resistance.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2009年第12期957-960,共4页 Chinese Journal of Contemporary Pediatrics
关键词 系膜增生性肾炎 CTLA-4 地塞米松 凋亡 儿童 Mesangial proliferative glomerulonephritis CTLA-4 Dexamethasone Apoptosis Child
  • 相关文献

参考文献15

  • 1Kato T, Nariuchi H. Polarization of naive CD4^+ T cells toward the Th1 subset by CTLA4 costimulation[ J]. J Immunol, 2000, 164 (7) :3554-3562.
  • 2Frauwirth KA, Thompson CB. Activation and inhibition of lymphocytes by costimulation[ J]. J Clin Invest, 2002, 109 (3) :295- 299.
  • 3Pare, RV, Chemnitz JM, Frauwirth KA, Lanfranco AR, Braunstein I, Kobavashi SV, et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms [ J ]. Mol Cell Biol, 2005, 25(21 ) :9543-9553.
  • 4Henson SM, Macaulav R, Kiani-Alikhan S, Akbar AN. The use of the inhibiotory receptors for modulating the immune responses [J]. Curt Pharm Des, 2008, 14(26) :2643-2650.
  • 5中华医学会儿科学分会肾脏病学组,姚勇,杨霁云,陈述枚,丁洁.小儿肾小球疾病的临床分类、诊断及治疗[J].中华儿科杂志,2001,39(12):746-749. 被引量:1533
  • 6Xia M, Gasser J, Feige U. Dexamethasone enhances CTLA4 expression during T cell activation [ J ]. Cell Mol Life Sci, 1999, 55 (12) : 1649-1656.
  • 7Koper JW, Stolk RP, Delange P, Huizenga NA, Molijn GJ, Pols HA, et al. Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance [J]. Hum Genet, 1997, 99(5) :663-668.
  • 8Linsley PS, Bradshaw J, Greene J, Peach R, Bennett KL, Mittler RS. Intracellular trafficking of CTLA~- and focal localization towards sites of TCR engagement [ J ]. Immunity, 1996, 4 ( 6 ) : 535- 543.
  • 9Egen JG, Kuhns MS, Allison JP. CTLA4: new insights into its biological function and use in tumor immunotherapy[J]. Nat Immunol, 2002, 3(7) :611-618.
  • 10Martin M, Schneider H, Azouz A, Rudd CE. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function [J]. J Exp Med, 2001, 194 ( 11 ) :1675-1681.

共引文献1532

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部